SCHEMBL8159583

SCHEMBL8159583

CCOc1c(C(C)(C)C)cc(C(C)=O)cc1C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 2/20 0.42
RXRA P19793 2/20 0.42
PPARG P37231 2/20 0.42
RARG P13631 1/20 0.42
TSHR P16473 2/20 0.42
CYP3A4 P08684 1/20 0.41
LMNA P02545 2/20 0.40
RECQL P46063 1/20 0.40
ESRRA P11474 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
KMT2A Q03164 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
HTT P42858 1/20 0.37
BRD4 O60885 1/20 0.37
BRD2 P25440 1/20 0.37
THRB P10828 1/20 0.37
GAA P10253 1/20 0.36
CA5A P35218 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1190498 0.90 TSHR (0.53) CREBBPTSHRCYP3A4LMNASMN1; SMN2
SCHEMBL1188354 0.90 ESRRA (0.42) CREBBPRXRAPPARGRARGTSHR
SCHEMBL16502258 0.90 RXRA (0.39) CREBBPRXRAPPARGRARGTSHR
SCHEMBL10204587 0.88 BPTF (0.49) CREBBPTSHRCYP3A4LMNASMN1; SMN2
SCHEMBL8008640 0.86 RXRA (0.44) RXRAPPARGRARGLMNARECQL
SCHEMBL7792646 0.86 TSHR (0.42) RXRAPPARGRARGTSHRLMNA
SCHEMBL14204866 0.86 ESRRA (0.40) LMNARECQLESRRASMN1; SMN2HSP90AA1
SCHEMBL10204490 0.85 RXRA (0.39) CREBBPRXRAPPARGRARGTSHR
SCHEMBL8000062 0.85 RXRA (0.46) RXRAPPARGRARGLMNAESRRA
SCHEMBL8000079 0.83 THRA (0.47) RXRAPPARGTHRBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083977-A HAVING ACTIVITY FOR RETINOIC ACID RECEPTORS AND RETINOID X RECEPTORS LIGAND PHARMACEUTICALS INCORPORATED (US) 2000-07-04 US disclosed
EP-0800503-B1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARM INC (US) 2000-05-10 EP disclosed
US-5721103-A SKIN DISORDERS; VISION DEFECTS LIGAND PHARMACEUTICALS INCORPORATED (US) 1998-02-24 US disclosed
EP-0800503-A1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS, INC. (US) 1997-10-15 EP disclosed
WO-1996020913-A1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 1996-07-11 WO disclosed